Seeking Alpha

LPTN
  Lpath Inc. - NASDAQ

11/24/2014, 9:14 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
LPTN vs. ETF Alternatives
Company Description
Lpath, Inc. is a biotechnology company engaged in the discovery and development of lipidomic-based therapeutic antibodies to treat a wide range of human diseases. The Company's product candidates include iSONEP, ASONEP, Lpathomab, and ImmuneY2 Technology.
Sector: Healthcare
Industry: Biotechnology
Country: United States